Skip to content
10-Q

Quarterly Report

BioCorRx Inc. BICX

0001477932-23-008379

← back to feed
Filed
Nov 14, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Nov 13, 2023 8.6M sh
Stockholders Equity Q3 2023 · Sep 30, 2023 −$9.13M
Stockholders Equity Q3 2023 · Dec 31, 2022 −$8.08M
Current Liabilities Q3 2023 · Sep 30, 2023 $5.95M
Current Liabilities Q3 2023 · Dec 31, 2022 $5.36M
Total Liabilities Q3 2023 · Sep 30, 2023 $9.79M
Total Liabilities Q3 2023 · Dec 31, 2022 $8.97M
Current Assets Q3 2023 · Sep 30, 2023 $245.79K
Current Assets Q3 2023 · Dec 31, 2022 $316.91K
Total Assets Q3 2023 · Sep 30, 2023 $534.45K
Total Assets Q3 2023 · Dec 31, 2022 $766.59K
Net Income Q3 2023 · Sep 30, 2023 −$2.8M
Net Income Q3 2023 · Sep 30, 2022 −$951.01K
Net Income Q3 2023 · Sep 30, 2022 −$3.21M
Net Income Q3 2023 · Jun 30, 2022 −$1.32M
Net Income Q3 2023 · Mar 31, 2022 −$944.99K
Shares Diluted Q3 2023 · Sep 30, 2022 1.43M sh
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$1.59M
Sga Expense Q3 2023 · Sep 30, 2022 $771.81K
Sga Expense Q3 2023 · Sep 30, 2022 $2.69M
Rd Expense Q3 2023 · Sep 30, 2022 $342.55K
Rd Expense Q3 2023 · Sep 30, 2022 $923.35K
Operating Income Q3 2023 · Sep 30, 2022 −$1.03M
Operating Income Q3 2023 · Sep 30, 2022 −$3.51M
Cost Of Revenue Q3 2023 · Sep 30, 2022 $2.34K
Cost Of Revenue Q3 2023 · Sep 30, 2022 $6.6K
Revenue Q3 2023 · Sep 30, 2022 $94.44K
Revenue Q3 2023 · Sep 30, 2022 $130.96K